2.5 million bottles of prescription eye drops recalled

Lupin Pharmaceuticals has issued a voluntary recall for more than 2.5 million bottles of its prednisolone acetate ophthalmic suspension. The decision follows the discovery of a foreign substance in the product. This medication is a common corticosteroid used to manage eye inflammation after surgery or for conditions like iritis and uveitis.

Patients currently using this prescription eye drop should verify the lot number on their vials against the official list provided by the FDA. If a bottle falls under the recall, users must contact their prescribing physician immediately to request a replacement. Do not stop using prescribed medication without consulting a doctor first, as sudden cessation can lead to complications for certain eye conditions.

Medical experts emphasize that this action is a standard part of the pharmaceutical quality control process. While reports of adverse events remain at zero, the recall serves as a precaution. Individuals using brands other than Lupin or products not on the specified list may continue their treatment as directed.

For those who need to confirm their supply, full details regarding the affected lot numbers, expiration dates, and NDC codes are available through the FDA website. Keep the original packaging or the bottle itself to easily reference the required information during your check.